November 2, 2026 · Climacteric : the journal of the International Menopause Society · DOI: 10.1080/13697137.2026.2745378

Perimenopause and cardiometabolic risk: emerging evidence, therapeutic opportunities and unanswered questions.

Listen to this summary

This review examines whether perimenopause, the transition period around the final menstrual period, represents a critical window where cardiometabolic risk and menopause symptoms intersect. The authors synthesize evidence that vasomotor symptoms and sleep disturbance are linked to adverse lipid, insulin, body composition, and vascular profiles, with autonomic, inflammatory, and neuroendocrine pathways as possible shared mechanisms. They conclude that the relationship appears bidirectional, but the absence of perimenopausal interventional studies leaves causality and whether targeting cardiometabolic health can improve both cardiovascular outcomes and symptoms unresolved.

Samar R El Khoudary, Isabella Deckey, Tiziana Fidecicchi, Tommaso Simoncini

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play